Il farmaco per carcinoma mammario “prezioso” trattenuto dal NHS nella riga dei prezzi
https://www.thetimes.com/article/2b11d605-195c-431f-b145-fe0c4e527820?shareToken=36ae821b105db630d80d30baa3e2cef0
di rezwenn
Il farmaco per carcinoma mammario “prezioso” trattenuto dal NHS nella riga dei prezzi
https://www.thetimes.com/article/2b11d605-195c-431f-b145-fe0c4e527820?shareToken=36ae821b105db630d80d30baa3e2cef0
di rezwenn
3 commenti
The pharmaceutical company won’t bother submitting it because they know that it’s way too expensive considering the effect. NICE will not approve it at the price offered.
The drug buys metastatic breast cancer patients about three extra months. Not to be sniffed at, but at around £45,000 per patient… it’s not worth it.
The NHS is close to a monopoly buyer of drugs in the UK and the ability to play hard ball is one reason why drugs are so much cheaper here than say the US.
Some of those drugs have terrible side effects
Seen some get access to one of the so called cancer wonder drugs, he said he wished he hadn’t and instead of have 3 more months that were utter hell, he would have preferred to have died sooner
Some of these drugs are simply put, not worth it, and you have to strike a balance between a longer life and a quality of life
And yeah, cost is a factor, the NHS cannot have an unlimited budget and if you get a couple more months from a drug that costs that much, you have to find another balance which is, if its better to extend someone’s life a short while, or put that money into something like better palliative care to make someone’s passing more comfortable, which will benefit far more people
I understand that bleeding edge drugs are very expensive, simply because the development and approval costs are so high, but that price is just not going to work